Skip to main content
Log in

Clinical characteristics of pulmonary artery involvement in patients with Behçet’s syndrome: single-centre experience of 61 patients

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Objective

To report the clinical characteristics of pulmonary artery involvement (PAI) in patients with Behçet’s syndrome (BS) and to define the predictors of relapses.

Methods

We performed retrospective analysis of BS patients with PAI who fulfilled international study group criteria. Among 460 patients with vascular Behçet’s syndrome (VBS), 66 were diagnosed with PAI. For final analyses, 61 patients with PAI were included who had at least 2 follow-up visits (72.1% male, mean age at BS diagnosis 29.34 ± 10.1 years). The patient data were recorded. Relapse was defined as the reoccurrence of vascular event in any vascular structure. Factors associated with relapse were assessed by logistic regression analysis.

Results

There were no differences considering demographic and clinical features of the patients with and without PAI in the VBS group, except that intracardiac thrombosis was more common in the patients with PAI (19.7% vs 0.3%). Among 61 patients, 50 (82.0%) had isolated pulmonary artery thrombosis (PAT), whereas 11 (18.0%) had pulmonary artery aneurysm with or without PAT. Twenty-four (39.3%) patients experienced vascular relapse during median follow-up of 65.9 (Q1-Q3: 20.1–109.0) months. To define the factors associated with relapses, patients with isolated PAT were analysed. On multivariable logistic regression analysis, older age at BS diagnosis and anticoagulation usage seemed to be protective (OR: 0.92, 95% CI 0.86–1.02, OR: 0.34, 95% CI 0.09–1.33, respectively).

Conclusion

Our results indicate a higher frequency of intracardiac thrombosis in BS patients with PAI and possible efficacy of anticoagulation usage in preventing relapses.

Key Points

• This study shows that intracardiac and intracranial thromboses are seen more frequently in patients with PAI and the prevalence of pulmonary artery thrombosis has been increasing in the case of PAI. Furthermore, our report indicates that anticoagulation might be effective in preventing further vascular relapses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Yazici H, Seyahi E, Hatemi G, Yazici Y (2018) Behçet syndrome: a contemporary view. Nat Rev Rheumatol 14(2):119. https://doi.org/10.1038/nrrheum.2018.3

    Article  PubMed  Google Scholar 

  2. Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, Yurdakul S, Yazici H (2003) The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82(1):60–76. https://doi.org/10.1097/00005792-200301000-00006

    Article  Google Scholar 

  3. Tascilar K, Melikoglu M, Ugurlu S, Sut N, Caglar E, Yazici H (2014) Vascular involvement in Behçet's syndrome: a retrospective analysis of associations and the time course. Rheumatology (Oxford) 53(11):2018–2022. https://doi.org/10.1093/rheumatology/keu233

    Article  CAS  Google Scholar 

  4. Seyahi E, Yazici H (2015) Behçet’s syndrome: pulmonary vascular disease. Curr Opin Rheumatol 27(1):18–23. https://doi.org/10.1097/bor.0000000000000131

    Article  PubMed  Google Scholar 

  5. Seyahi E, Melikoglu M, Akman C, Hamuryudan V, Ozer H, Hatemi G, Yurdakul S, Tuzun H, Oz B, Yazici H (2012) Pulmonary artery involvement and associated lung disease in Behçet disease: a series of 47 patients. Medicine (Baltimore) 91(1):35–48. https://doi.org/10.1097/MD.0b013e318242ff37

    Article  Google Scholar 

  6. Raz I, Okon E, Chajek-Shaul T (1989) Pulmonary manifestations in Behçet's syndrome. Chest 95(3):585–589. https://doi.org/10.1378/chest.95.3.585

    Article  CAS  PubMed  Google Scholar 

  7. Edrees A, Naguib S, El Menyawi M, Ismail I, Nagah H (2017) Pulmonary manifestations in a group of patients with Behcet's disease. Int J Rheum Dis 20(2):269–275. https://doi.org/10.1111/1756-185x.12626

    Article  PubMed  Google Scholar 

  8. Hamuryudan V, Yurdakul S, Moral F, Numan F, Tüzün H, Tüzüner N, Mat C, Tüzün Y, Ozyazgan Y, Yazïci H (1994) Pulmonary arterial aneurysms in Behçet's syndrome: a report of 24 cases. Br J Rheumatol 33(1):48–51. https://doi.org/10.1093/rheumatology/33.1.48

    Article  CAS  PubMed  Google Scholar 

  9. Hamuryudan V, Er T, Seyahi E, Akman C, Tüzün H, Fresko I, Yurdakul S, Numan F, Yazici H (2004) Pulmonary artery aneurysms in Behçet syndrome. Am J Med 117(11):867–870. https://doi.org/10.1016/j.amjmed.2004.05.027

    Article  PubMed  Google Scholar 

  10. Saadoun D, Wechsler B, Desseaux K, Le Thi HD, Amoura Z, Resche-Rigon M, Cacoub P (2010) Mortality in Behçet's disease. Arthritis Rheum 62(9):2806–2812. https://doi.org/10.1002/art.27568

    Article  CAS  PubMed  Google Scholar 

  11. Uzun O, Akpolat T, Erkan L (2005) Pulmonary vasculitis in behcet disease: a cumulative analysis. Chest 127(6):2243–2253. https://doi.org/10.1378/chest.127.6.2243

    Article  PubMed  Google Scholar 

  12. Ozguler Y, Dincses E, Bakan S, Hatemi G, Melikoglu M, Ugurlu S, Yurdakul S, Yazici H, Seyahi E (2018) SAT0525 An update on pulmonary artery involvement in behcet’s syndrome: more pulmonary artery thrombotic disease and a better outcome. Ann Rheum Dis 77(Suppl 2):1118. https://doi.org/10.1136/annrheumdis-2018-eular.6675

    Article  Google Scholar 

  13. Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A, Kötter I, Leccese P, Mahr A, Moots R, Ozguler Y, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H (2018) 2018 update of the EULAR recommendations for the management of Behçet's syndrome. Ann Rheum Dis 77(6):808–818. https://doi.org/10.1136/annrheumdis-2018-213225

    Article  PubMed  Google Scholar 

  14. Tuzun H, Seyahi E, Guzelant G, Oz B, Batur S, Demirhan O, Hamuryudan V (2018) Surgical Treatment of Pulmonary Complications in Behçet's Syndrome. Semin Thorac Cardiovasc Surg 30(3):369–378. https://doi.org/10.1053/j.semtcvs.2018.07.008

    Article  PubMed  Google Scholar 

  15. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease (1990). Lancet 335 (8697):1078-1080

  16. Saadoun D, Asli B, Wechsler B, Houman H, Geri G, Desseaux K, Piette JC, Huong du LT, Amoura Z, Salem TB, Cluzel P, Koskas F, Resche-Rigon M, Cacoub P (2012) Long-term outcome of arterial lesions in Behçet disease: a series of 101 patients. Medicine (Baltimore) 91 (1):18-24. doi:https://doi.org/10.1097/MD.0b013e3182428126

  17. Wu X, Li G, Huang X, Wang L, Liu W, Zhao Y, Zheng W (2014) Behçet's disease complicated with thrombosis: a report of 93 Chinese cases. Medicine (Baltimore) 93(28):e263. https://doi.org/10.1097/md.0000000000000263

    Article  Google Scholar 

  18. Kechida M, Salah S, Kahloun R, Klii R, Hammami S, Khochtali I (2018) Cardiac and vascular complications of Behçet disease in the Tunisian context: clinical characteristics and predictive factors. Advances in Rheumatology 58:32

    Article  Google Scholar 

  19. Chen Y, Cai JF, Lin CH, Guan JL (2019) Demography of vascular Behcet's disease with different gender and age: an investigation with 166 Chinese patients. Orphanet J Rare Dis 14(1):88. https://doi.org/10.1186/s13023-019-1061-1

    Article  PubMed  PubMed Central  Google Scholar 

  20. Tunaci M, Ozkorkmaz B, Tunaci A, Gül A, Engin G, Acunaş B (1999) CT findings of pulmonary artery aneurysms during treatment for Behçet's disease. AJR Am J Roentgenol 172(3):729–733. https://doi.org/10.2214/ajr.172.3.10063870

    Article  CAS  PubMed  Google Scholar 

  21. Uzun O, Erkan L, Akpolat I, Findik S, Atici AG, Akpolat T (2008) Pulmonary involvement in Behçet's disease. Respiration 75(3):310–321. https://doi.org/10.1159/000101954

    Article  PubMed  Google Scholar 

  22. Zhang X, Dai H, Ma Z, Yang Y, Liu Y (2015) Pulmonary involvement in patients with Behçet's disease: report of 15 cases. Clin Respir J 9(4):414–422. https://doi.org/10.1111/crj.12153

    Article  PubMed  Google Scholar 

  23. Seyahi E, Karaaslan H, Ugurlu S, Yazici H (2013) Fever in Behçet's syndrome. Clin Exp Rheumatol 31(3 Suppl 77):64–67

    PubMed  Google Scholar 

  24. Zhou J, Shi J, Liu J, Sun L, Li L, Li C, Wu X, Wang Y, Tian X, Zeng X, Liu Y, Zheng W, Zhao Y (2019) The Clinical Features, Risk Factors, and Outcome of Aneurysmal Lesions in Behcet's Disease. J Immunol Res 2019:9198506–9198508. https://doi.org/10.1155/2019/9198506

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Emmungil H, Yaşar Bilge N, Küçükşahin O, Kılıç L, Okutucu S, Gücenmez S, Kalyoncu U, Kaşifoğlu T, Turgay M, Aksu K (2014) A rare but serious manifestation of Behçet's disease: intracardiac thrombus in 22 patients. Clin Exp Rheumatol 32(4 Suppl 84):S87–S92

    PubMed  Google Scholar 

  26. Gurcan M, Esatoglu SN, Hamuryudan V, Saygin D, Ugurlu S, Seyahi E, Melikoglu M, Fresko I, Yurdakul S, Yazici H, Hatemi G (2020) Long term follow-up of Behçet's syndrome patients treated with cyclophosphamide. Rheumatology (Oxford) 59(9):2264–2271. https://doi.org/10.1093/rheumatology/kez598

    Article  CAS  Google Scholar 

  27. Hamuryudan V, Seyahi E, Ugurlu S, Melikoglu M, Hatemi G, Ozguler Y, Akman C, Tuzun H, Yurdakul S, Yazici H (2015) Pulmonary artery involvement in Behçet′s syndrome: Effects of anti-Tnf treatment. Semin Arthritis Rheum 45(3):369–373. https://doi.org/10.1016/j.semarthrit.2015.06.008

    Article  CAS  PubMed  Google Scholar 

  28. Desbois AC, Wechsler B, Resche-Rigon M, Piette JC, Huong Dle T, Amoura Z, Koskas F, Desseaux K, Cacoub P, Saadoun D (2012) Immunosuppressants reduce venous thrombosis relapse in Behçet's disease. Arthritis Rheum 64(8):2753–2760. https://doi.org/10.1002/art.34450

    Article  CAS  PubMed  Google Scholar 

  29. Alibaz-Oner F, Karadeniz A, Ylmaz S, Balkarl A, Kimyon G, Yazc A, Çnar M, Ylmaz S, Yldz F, Bilge ŞY, Bilgin E, Coskun BN, Omma A, Çetin GY, Çağatay Y, Karaaslan Y, Sayarlioğlu M, Pehlivan Y, Kalyoncu U, Karadağ Ö, Kaşifoğlu T, Erken E, Pay S, Çefle A, Kisacik B, Onat AM, Çobankara V, Direskeneli H (2015) Behçet disease with vascular involvement: effects of different therapeutic regimens on the incidence of new relapses. Medicine (Baltimore) 94(6):e494. https://doi.org/10.1097/md.0000000000000494

    Article  CAS  Google Scholar 

  30. Ahn JK, Lee YS, Jeon CH, Koh EM, Cha HS (2008) Treatment of venous thrombosis associated with Behcet's disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation. Clin Rheumatol 27(2):201–205. https://doi.org/10.1007/s10067-007-0685-z

    Article  PubMed  Google Scholar 

  31. Seyahi E, Cakmak OS, Tutar B, Arslan C, Dikici AS, Sut N, Kantarci F, Tuzun H, Melikoglu M, Yazici H (2015) Clinical and Ultrasonographic Evaluation of Lower-extremity Vein Thrombosis in Behcet Syndrome: An Observational Study. Medicine (Baltimore) 94(44):e1899. https://doi.org/10.1097/md.0000000000001899

    Article  Google Scholar 

  32. Ozguler Y, Hatemi G, Cetinkaya F, Tascilar K, Hamuryudan V, Ugurlu S, Seyahi E, Yazici H, Melikoglu M (2020) Clinical course of acute deep vein thrombosis of the legs in Behçet's syndrome. Rheumatology (Oxford) 59(4):799–806. https://doi.org/10.1093/rheumatology/kez352

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Didem Sahin Eroglu.

Ethics declarations

Disclosures

None

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eroglu, D.S., Torgutalp, M., Baysal, S. et al. Clinical characteristics of pulmonary artery involvement in patients with Behçet’s syndrome: single-centre experience of 61 patients. Clin Rheumatol 40, 4127–4134 (2021). https://doi.org/10.1007/s10067-021-05748-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-021-05748-x

Keywords

Navigation